Irradiated Blood Components
IRRADIATED BLOOD COMPONENTS
Transfusion-associated graft-versus-host disease (GVHD), a frequently fatal condition, can be minimized through the use of highly selected irradiated blood components. Patients who are at risk of GVHD include recipients of donor-directed units or HLA-matched platelets, fetuses receiving intrauterine transfusions, and selected immunocompromised and bone marrow recipients.